The expression of the BPIFB4 and CXCR4 associates with sustained health in long-living individuals from Cilento-Italy

Aging

Volumn 9, Issue 2, 2017, Pages 370-380

  Spinetti, Gaia ^a   Sangalli, Elena ^a   Specchia, Claudia ^a,b   Villa, Francesco ^a   Spinelli, Chiara ^a   Pipolo, Rita ^c   Carrizzo, Albino ^d   Greco, Simona ^e   Voellenkle, Christine ^e   Vecchione, Carmine ^c,d   Madeddu, Paolo ^f   Martelli, Fabio ^e   Puca, Annibale Alessandro ^a,c  

^a IRCCS MULTIMEDICA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF SALERNO   (Italy)

^d IRCCS NEUROMED   (Italy)

^e IRCCS POLICLINICO SAN DONATO   (Italy)

^f UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

BPIFB4; CXCR4; HIF 1 targets; Long living individuals; Mononuclear cell migration

Indexed keywords

ADM PROTEIN, HUMAN; ADRENOMEDULLIN; BPIFB4 PROTEIN, HUMAN; CHEMOKINE RECEPTOR CXCR4; CXCR4 PROTEIN, HUMAN; GLUCOSE TRANSPORTER 1; PHOSPHOPROTEIN; VASCULOTROPIN A;

AGING; CELL MOTION; CYTOLOGY; FEMALE; GENETICS; HEALTH STATUS; HUMAN; ITALY; LONGEVITY; MALE; METABOLISM; MONONUCLEAR CELL; PHYSIOLOGY; VERY ELDERLY;

ADRENOMEDULLIN; AGED, 80 AND OVER; AGING; CELL MOVEMENT; FEMALE; GLUCOSE TRANSPORTER TYPE 1; HEALTH STATUS; HUMANS; ITALY; LEUKOCYTES, MONONUCLEAR; LONGEVITY; MALE; PHOSPHOPROTEINS; RECEPTORS, CXCR4; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 85014426961     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.101159     Document Type: Article

References (31)

1. Fleg JL, Aronow WS, Frishman WH. Cardiovascular drug therapy in the elderly: benefits and challenges. Nat Rev Cardiol. 2011; 8:13-28. doi: 10.1038/nrcardio.2010.162
2. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong Y, Johnston SC, Khera A, Lloyd-Jones DM, Nelson SA, Nichol G, et al, and American Heart Association Advocacy Coordinating Committee, and Stroke Council, and Council on Cardiovascular Radiology and Intervention, and Council on Clinical Cardiology, and Council on Epidemiology and Prevention, and Council on Arteriosclerosis, and Thrombosis and Vascular Biology, and Council on Cardiopulmonary, and Critical Care, and Perioperative and Resuscitation, and Council on Cardiovascular Nursing, and Council on the Kidney in Cardiovascular Disease, and Council on Cardiovascular Surgery and Anesthesia, and Interdisciplinary Council on Quality of Care and Outcomes Research. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011; 123:933-44. doi: 10.1161/CIR.0b013e31820a55f5
3. Rae MJ, Butler RN, Campisi J, de Grey AD, Finch CE, Gough M, Martin GM, Vijg J, Perrott KM, Logan BJ. The demographic and biomedical case for late-life interventions in aging. Sci Transl Med. 2010; 2:40cm21. doi: 10.1126/scitranslmed.3000822
4. Villa F, Carrizzo A, Spinelli CC, Ferrario A, Malovini A, Maciag A, Damato A, Auricchio A, Spinetti G, Sangalli E, Dang Z, Madonna M, Ambrosio M, et al. Genetic Analysis Reveals a Longevity-Associated Protein Modulating Endothelial Function and Angiogenesis. Circ Res. 2015; 117:333-45. doi: 10.1161/CIRCRESAHA.117.305875
5. Villa F, Malovini A, Carrizzo A, Spinelli CC, Ferrario A, Maciag A, Madonna M, Bellazzi R, Milanesi L, Vecchione C, Puca AA. Serum BPIFB4 levels classify health status in long-living individuals. Immun Ageing. 2015; 12:27. doi: 10.1186/s12979-015-0054-8
6. Zhang W, Shi X, Peng Y, Wu M, Zhang P, Xie R, Wu Y, Yan Q, Liu S, Wang J. HIF-1 alpha Promotes Epithelial-Mesenchymal Transition and Metastasis through Direct Regulation of ZEB1 in Colorectal Cancer. PLoS One. 2015; 10:e0129603. doi: 10.1371/journal.pone.0129603
7. Shen C, Nettleton D, Jiang M, Kim SK, Powell-Coffman JA. Roles of the HIF-1 hypoxia-inducible factor during hypoxia response in Caenorhabditis elegans. J Biol Chem. 2005; 280:20580-88. doi: 10.1074/jbc.M501894200
8. Semenza GL. Hypoxia-inducible factor 1 and cardiovascular disease. Annu Rev Physiol. 2014; 76:39-56. doi: 10.1146/annurev-physiol-021113-170322
9. Greco S, Gorospe M, Martelli F. Noncoding RNA in age-related cardiovascular diseases. J Mol Cell Cardiol. 2015; 83:142-55. doi: 10.1016/j.yjmcc.2015.01.011
10. Greco S, Gaetano C, Martelli F. HypoxamiR regulation and function in ischemic cardiovascular diseases. Antioxid Redox Signal. 2014; 21:1202-19. doi: 10.1089/ars.2013.5403
11. Cottrill KA, Chan SY, Loscalzo J. Hypoxamirs and mitochondrial metabolism. Antioxid Redox Signal. 2014; 21:1189-201. doi: 10.1089/ars.2013.5641
12. Fasanaro P, D'Alessandra Y, Di Stefano V, Melchionna R, Romani S, Pompilio G, Capogrossi MC, Martelli F. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem. 2008; 283:15878-83. doi: 10.1074/jbc.M800731200
13. Hu S, Huang M, Li Z, Jia F, Ghosh Z, Lijkwan MA, Fasanaro P, Sun N, Wang X, Martelli F, Robbins RC, Wu JC. MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation. 2010; 122:S124-31. doi: 10.1161/CIRCULATIONAHA.109.928424
14. Liu F, Lou YL, Wu J, Ruan QF, Xie A, Guo F, Cui SP, Deng ZF, Wang Y. Upregulation of microRNA-210 regulates renal angiogenesis mediated by activation of VEGF signaling pathway under ischemia/perfusion injury in vivo and in vitro. Kidney Blood Press Res. 2012; 35:182-91. doi: 10.1159/000331054
15. Liu SC, Chuang SM, Hsu CJ, Tsai CH, Wang SW, Tang CH. CTGF increases vascular endothelial growth factor-dependent angiogenesis in human synovial fibroblasts by increasing miR-210 expression. Cell Death Dis. 2014; 5:e1485. doi: 10.1038/cddis.2014.453
16. Alaiti MA, Ishikawa M, Masuda H, Simon DI, Jain MK, Asahara T, Costa MA. Up-regulation of miR-210 by vascular endothelial growth factor in ex vivo expanded CD34+ cells enhances cell-mediated angiogenesis. J Cell Mol Med. 2012; 16:2413-21. doi: 10.1111/j.1582-4934.2012.01557.x
17. Zeng L, He X, Wang Y, Tang Y, Zheng C, Cai H, Liu J, Wang Y, Fu Y, Yang GY. MicroRNA-210 overexpression induces angiogenesis and neurogenesis in the normal adult mouse brain. Gene Ther. 2014; 21:37-43. doi: 10.1038/gt.2013.55
18. Cappuzzello C, Napolitano M, Arcelli D, Melillo G, Melchionna R, Di Vito L, Carlini D, Silvestri L, Brugaletta S, Liuzzo G, Crea F, Capogrossi MC. Gene expression profiles in peripheral blood mononuclear cells of chronic heart failure patients. Physiol Genomics. 2009; 38:233-40. doi: 10.1152/physiolgenomics.90364.2008
19. Voellenkle C, van Rooij J, Cappuzzello C, Greco S, Arcelli D, Di Vito L, Melillo G, Rigolini R, Costa E, Crea F, Capogrossi MC, Napolitano M, Martelli F. MicroRNA signatures in peripheral blood mononuclear cells of chronic heart failure patients. Physiol Genomics. 2010; 42:420-26. doi: 10.1152/physiolgenomics.00211.2009
20. Fortunato O, Spinetti G, Specchia C, Cangiano E, Valgimigli M, Madeddu P. Migratory activity of circulating progenitor cells and serum SDF-1a predict adverse events in patients with myocardial infarction. Cardiovasc Res. 2013; 100:192-200. doi: 10.1093/cvr/cvt153
21. Spinetti G, Specchia C, Fortunato O, Sangalli E, Clerici G, Caminiti M, Airoldi F, Losa S, Emanueli C, Faglia E, Madeddu P. Migratory activity of circulating mononuclear cells is associated with cardiovascular mortality in type 2 diabetic patients with critical limb ischemia. Diabetes Care. 2014; 37:1410-17. doi: 10.2337/dc13-2084
22. Seeger FH, Rasper T, Koyanagi M, Fox H, Zeiher AM, Dimmeler S. CXCR4 expression determines functional activity of bone marrow-derived mononuclear cells for therapeutic neovascularization in acute ischemia. Arterioscler Thromb Vasc Biol. 2009; 29:1802-09. doi: 10.1161/ATVBAHA.109.194688
23. Malovini A, Illario M, Iaccarino G, Villa F, Ferrario A, Roncarati R, Anselmi CV, Novelli V, Cipolletta E, Leggiero E, Orro A, Rusciano MR, Milanesi L, et al. Association study on long-living individuals from Southern Italy identifies rs10491334 in the CAMKIV gene that regulates survival proteins. Rejuvenation Res. 2011; 14:283-91. doi: 10.1089/rej.2010.1114
24. Leiser SF, Kaeberlein M. The hypoxia-inducible factor HIF-1 functions as both a positive and negative modulator of aging. Biol Chem. 2010; 391:1131-37. doi: 10.1515/bc.2010.123
25. Leiser SF, Miller H, Rossner R, Fletcher M, Leonard A, Primitivo M, Rintala N, Ramos FJ, Miller DL, Kaeberlein M. Cell nonautonomous activation of flavin-containing monooxygenase promotes longevity and health span. Science. 2015; 350:1375-78.doi: 10.1126/science.aac9257
26. Keith B, Johnson RS, Simon MC. HIF1a and HIF2a: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer. 2011; 12:9-22. doi: 10.1038/nrc3183
27. Mole DR, Blancher C, Copley RR, Pollard PJ, Gleadle JM, Ragoussis J, Ratcliffe PJ. Genome-wide association of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha DNA binding with expression profiling of hypoxia-inducible transcripts. J Biol Chem. 2009; 284:16767-75. doi: 10.1074/jbc.M901790200
28. Schödel J, Oikonomopoulos S, Ragoussis J, Pugh CW, Ratcliffe PJ, Mole DR. High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq. Blood. 2011; 117:e207-17. doi: 10.1182/blood-2010-10-314427
29. Chen KC, Liao YC, Wang JY, Lin YC, Chen CH, Juo SH. Oxidized low-density lipoprotein is a common risk factor for cardiovascular diseases and gastroenterological cancers via epigenomical regulation of microRNA-210. Oncotarget. 2015; 6:24105-18. doi: 10.18632/oncotarget.4152
30. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001; 29:e45. doi: 10.1093/nar/29.9.e45
31. Caporali A, Meloni M, Völlenkle C, Bonci D, Sala-Newby GB, Addis R, Spinetti G, Losa S, Masson R, Baker AH, Agami R, le Sage C, Condorelli G, et al. Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia. Circulation. 2011; 123:282-91. doi: 10.1161/CIRCULATIONAHA.110.952325